Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06003985 · ClinicalTrials.gov registry record
Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists
A clinical trial of Point-of-care Ultrasound and Gastric Ultrasound, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- 354
- Enrollment target
- 8
- Study locations
NCT06003985: Completed study of Point-of-care Ultrasound and Gastric Ultrasound, sponsored by Hospital for Special Surgery, New York.
NCT06003985 is a study of Point-of-care Ultrasound and Gastric Ultrasound that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 354 participants. The trial reports 8 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06003985, a study of Point-of-care Ultrasound and Gastric Ultrasound, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- 354 participants
- Enrollment target
- 8
- Study locations
Study Summary
The aim of this study is to perform bedside gastric point of care ultrasound (POCUS) exams to assess the gastric volume and content (clear liquids vs solid food) perioperatively in patients who take glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists.
Primary Outcome
delayed gastric emptying is defined by the presence of either solid food, thick liquids or a specific volume (\>1.5 ml/kg) of clear liquids on gastric ultrasound.
Conditions Studied
Interventions
- OTHER Gastric Ultrasound Exam
Study Locations (8)
New York
- Albany Medical Center - Albany
- Hospital for Special Surgery - New York
- Memorial Sloan Kettering Cancer Center - New York
- Weill Cornell Medicine - New York
District of Columbia
- George Washington University Hospital - Washington D.C.
Florida
- Mayo Clinic - Jacksonville
Virginia
- University of Virginia - Charlottesville
Ontario
- University Health Network - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 354 participants |
| Start Date | 2023-08-29 |
| Est. Completion | 2025-02-01 |
What the finished NCT06003985 record still lists
NCT06003985 is an observational study that tracks outcomes without assigning an intervention. The registered 354 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Point-of-care Ultrasound appearing as the primary indexed condition, and to 1 intervention - of which Gastric Ultrasound Exam is the first listed.
NCT06003985 lists 8 locations in 5 states (New York, District of Columbia, Florida).
Frequently Asked Questions
What is clinical trial NCT06003985 about?
NCT06003985 is a clinical study titled "Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists". The aim of this study is to perform bedside gastric point of care ultrasound (POCUS) exams to assess the gastric volume and content (clear liquids vs solid food) perioperatively in patients who take glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonis...
What is the current status of trial NCT06003985?
This trial is currently completed. The enrollment target is 354 participants. The study started on 2023-08-29. Estimated completion is 2025-02-01.
What conditions does trial NCT06003985 study?
This clinical trial studies the following conditions: Point-of-care Ultrasound, Gastric Ultrasound, Glucagon-like Peptide 1.
What interventions are being tested in trial NCT06003985?
The interventions under investigation include: Gastric Ultrasound Exam (OTHER).
Who is sponsoring clinical trial NCT06003985?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06003985 being conducted?
This trial has 8 study locations across District of Columbia, Florida, New York, Virginia, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Point-of-care Ultrasound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02579967 · 354 participants · Phase 2
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- NCT02610413 · 354 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
- NCT05729256 · 354 participants · NA
Alcohol and "Heat of the Moment" Sexual Decision Making
- NCT06507618 · 354 participants · Phase 3
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI